Exposure to PM elicits widespread transcriptional alterations in the brains of transgenic AD mice, thus expediting the progression of AD-associated pathology, including increased amyloid-β42 expression and tau phosphorylation (6). This evidence concerns the gene MAPT and Alzheimer disease.